Self-management of diabetes can be more successful when telemonitoring is included.
Read More »Evaluation of an Interoperable Artificial Pancreas System (iAPS)
An interoperable artificial pancreas system smartphone app was designed, developed, and tested to make decision-making algorithms while running on an unlocked smartphone. An Artificial Pancreas system closes the loop between a continuous glucose monitor (CGM) and an insulin pump by creating an algorithm that adjusts the insulin dose to control blood glucose …
Read More »Children with Type 1 Diabetes and the Artificial Pancreas
Less than 20% of children with type 1 diabetes attain the target glycated hemoglobin level of less than 7% recommended by the American Diabetes Association.
Read More »Omnipod Horizon System in Children with Type 1 Diabetes
The first study conducted on this device that explores the effectiveness and safety parameters.
Read More »Telemedicine For Management of Diabetes Amid COVID-19 Concerns: Does It Work?
Patients are relieved to know that care continues through the coronavirus pandemic.
Read More »Hybrid Closed-Loop Insulin Delivery for Children
Young children with type 1 diabetes often experience greater insulin variability, leading to more complications and a subpar quality of life.
Read More »Real-World Evidence in Support of Continuous Glucose Monitoring
Insulin delivery method or blood glucose monitoring – which is more important?
Read More »The Positives and Negatives for Continuous Glucose Monitoring in Young Children
CGM use in young children with type 1 diabetes has its benefits and challenges, according to their parents.
Read More »New Look at CGM in Expecting Mothers
Evidence suggests that pregnant women with type 1 diabetes can achieve optimal glucose control based on temporal glucose profiles.
Read More »Do-It-Yourself Artificial Pancreas for Type 1 Patients
The do-it-yourself artificial pancreas systems (DIYAPS) offer a solution to patients who lack access to, or can’t afford, other technological options.
Read More »